InChI=1S/C8H12N4O5/c9- 7- 10- 2- 12(8(16) 11- 7) 6- 5(15) 4(14) 3(1- 13) 17- 6/h2- 6,13- 15H,1H2,(H2,9,11,16) /t3- ,4- ,5+,6- /m1/s1 |
NMUSYJAQQFHJEW-ARQDHWQXSA-N |
[C@H]1(O[C@@H]([C@H]([C@@H]1O)O)CO)N2C=NC(=NC2=O)N |
|
antineoplastic agent
A substance that inhibits or prevents the proliferation of neoplasms.
|
|
View more via ChEBI Ontology
4-amino-1-β-D-arabinofuranosyl-1,3,5-triazin-2(1H)-one
|
fazarabina
|
WHO MedNet
|
fazarabine
|
WHO MedNet
|
fazarabine
|
ChemIDplus
|
fazarabinum
|
WHO MedNet
|
1-beta-D-Arabinofuranosyl-5-azacytosine
|
ChemIDplus
|
4-Amino-1-beta-D-arabinofuranosyl-s-triazin-2(1H)-one
|
ChemIDplus
|
5-azacytarabine
|
ChEBI
|
5-azacytosine arabinoside
|
ChemIDplus
|
Ara-AC
|
ChemIDplus
|
620462
|
Reaxys Registry Number
|
Reaxys
|
65886-71-7
|
CAS Registry Number
|
ChemIDplus
|
10492074
|
PubMed citation
|
Europe PMC
|
1376722
|
PubMed citation
|
Europe PMC
|
29438107
|
PubMed citation
|
Europe PMC
|
7678714
|
PubMed citation
|
Europe PMC
|
9414404
|
PubMed citation
|
Europe PMC
|
|